Intradiabodies, bispecific, tetravalent antibodies for the simultaneous functional knockout of two cell surface receptors.
about
Specific in vivo knockdown of protein function by intrabodiesImmunocytokines and bispecific antibodies: two complementary strategies for the selective activation of immune cells at the tumor siteA current perspective on applications of macrocyclic-peptide-based high-affinity ligandsGeneration of anti-TLR2 intrabody mediating inhibition of macrophage surface TLR2 expression and TLR2-driven cell activation.Generation of functional scFv intrabody to abate the expression of CD147 surface molecule of 293A cellsEngineering of stable bispecific antibodies targeting IL-17A and IL-23.Phenotypic knockout of VEGF-R2 and Tie-2 with an intradiabody reduces tumor growth and angiogenesis in vivoRecombinant bispecific antibodies for cancer therapy.Antibody engineering: facing new challenges in cancer therapy.Nanocell targeting using engineered bispecific antibodies.Antibody-based antiangiogenic cancer therapy.Blocking translocation of cell surface molecules from the ER to the cell surface by intracellular antibodies targeted to the ER.Application of bispecific antibody against antigen and hapten for immunodetection and immunopurification.From rabbit antibody repertoires to rabbit monoclonal antibodiesExploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity.Mining Naïve Rabbit Antibody Repertoires by Phage Display for Monoclonal Antibodies of Therapeutic Utility.Recent Advances with ER Targeted Intrabodies.The potential for cancer combination therapy with multi-targeted, single-protein pharmaceuticals.
P2860
Q26801077-53C949A1-E1FF-4EAE-807F-62E99EF98114Q28066935-1F6142E9-6985-4101-B640-411FBA6DE2B0Q28072407-3187A31E-2DC3-437D-AF01-A51F264D47ECQ30980638-136EAEBD-D961-4629-9D90-CF92B85DD207Q33316880-244E9DF8-3D48-4B58-A79A-7162ACD79FE0Q33519833-8598FEFD-56F3-49A4-B467-7F698965C0D9Q33852232-B12D3EAB-C43C-4835-A45A-AB2D40FD08AAQ36013830-545F3DE9-6C2B-447B-BF0B-1806677663F7Q36139507-F00D5257-14B2-4C8D-AA8B-2127ACB8114FQ36211456-C8CD4B36-AA4F-4F57-8B73-3F35B3D0CCC0Q36318555-3B2F581B-6314-4237-9954-40C1EE12E5ABQ36762625-9F86D183-7E51-4265-96BD-DD6BA76D2262Q37212191-73B82446-1FD8-4DFD-9C89-5877C8E1D34FQ37739483-E1ABE210-BC1B-4B72-8809-32E67639B873Q37997765-A911C462-F9E7-4CD2-BE40-3A134841B329Q38429183-8600E41C-DC98-463B-8663-A9853F19EC99Q38861174-21E8057D-C25D-480F-A84E-24D5EB298017Q47952691-2044B0F6-66E5-4F9C-8AB3-7DB369822C2F
P2860
Intradiabodies, bispecific, tetravalent antibodies for the simultaneous functional knockout of two cell surface receptors.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Intradiabodies, bispecific, te ...... of two cell surface receptors.
@ast
Intradiabodies, bispecific, te ...... of two cell surface receptors.
@en
type
label
Intradiabodies, bispecific, te ...... of two cell surface receptors.
@ast
Intradiabodies, bispecific, te ...... of two cell surface receptors.
@en
prefLabel
Intradiabodies, bispecific, te ...... of two cell surface receptors.
@ast
Intradiabodies, bispecific, te ...... of two cell surface receptors.
@en
P2093
P2860
P356
P1476
Intradiabodies, bispecific, te ...... of two cell surface receptors
@en
P2093
Carlos F Barbas
Junho Chung
Mikhail Popkov
Nina Jendreyko
Roger R Beerli
P2860
P304
47812-47819
P356
10.1074/JBC.M307002200
P407
P577
2003-08-28T00:00:00Z